Bone Mineral Density and Fractures in Antiretroviral-Naive Persons Randomized to Receive Abacavir-Lamivudine or Tenofovir Disoproxil Fumarate-Emtricitabine Along With Efavirenz or Atazanavir-Ritonavir: AIDS Clinical Trials Group A5224s, a Substudy of ACTG A5202

(See the editorial commentary by Yin and Overton, on pages 1705-7.) Background.  Long-term effects of abacavir (ABC)–lamivudine (3TC), compared with tenofovir (TDF)–emtricitabine (FTC) with efavirenz (EFV) or atazanavir plus ritonavir (ATV/r), on bone mineral density (BMD) have not been analyzed. Me...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McComsey, Grace A., Kitch, Douglas, Daar, Eric S., Tierney, Camlin, Jahed, Nasreen C., Tebas, Pablo, Myers, Laurie, Melbourne, Kathleen, Ha, Belinda, Sax, Paul E.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Major Articles and Brief Reports
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3100514/
https://ncbi.nlm.nih.gov/pubmed/21606537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jir188
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados